BPaL

TB Alliance and Lupin Announce Commercial Partnership for New Therapy for Highly Drug-Resistant TB

Mumbai, September 06, 2021: Non-profit drug developer, TB Alliance has granted global pharma major Lupin Limited (Lupin), a non-exclusive license…

3 years ago